Last Updated: May 20, 2026

Claims for Patent: 10,697,960

✉ Email this page to a colleague

Summary for Patent: 10,697,960

Title:	CXCR4 and ROBO1 expression as markers for autoimmune diabetes
Abstract:	CXCR4 and ROBO-1 are biomarkers associated with type 1 diabetes. Expression of CXCR4 and ROBO-1 in peripheral CD3 T cells is substantially higher in patients with autoimmune diabetes (type 1 diabetes) than in non-diabetic patients. Therapies are disclosed for reducing the progression of type 1 diabetes, and to reduce the risk of developing type 1 diabetes in patients who are at risk of developing type 1 diabetes.
Inventor(s):	Christopher KEVIL, Robert McVie, John Glawe
Assignee:	Board Of Supervisors Or Louisana State University And Agricultural And Mechanical College , Louisiana State University
Application Number:	US14/950,202

Details for Patent 10,697,960

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Kite Pharma Inc.	TECARTUS	brexucabtagene autoleucel	For Injection	125703	July 24, 2020	⤷ Start Trial	2035-11-24
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,697,960

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
United States of America	9234886	⤷ Start Trial
United States of America	2016146807	⤷ Start Trial
United States of America	2014073565	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.